Showing results (161-170 of 259) with videos related to
Sort By:
Pageof 26
ACS Nano|January 17, 2025
PEGylated Ultrasmall Iron Oxide Nanoparticles as MRI Contrast Agents for Vascular Imaging and Real-Time MonitoringKuan Lu, Ruru Zhang, Hongzhao Wang, et al.Journal of Nanobiotechnology|January 20, 2026
Injectable multi-component hydrogels for the treatment of ascites caused by hepatocellular carcinoma via anti-tumor and reduction of ascites generationYuqin Yang, Jinchai Qi, Yingqi Lang, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|September 15, 2025
Hypertension and BMI as Mediators of Type 2 Diabetes-Induced CKD: Insights from an Integrative Multi-Database StudyHeng Wang, Keyi Fan, Yijie Ning, et al.Journal of the American Heart Association|December 10, 2021
Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global RegistryRoberto Rordorf, Fernando Scazzuso, Kyoung Ryul Julian Chun, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responsesSonali Joshi, Surinder Kaur, Amanda J Redig, et al.Journal of Clinical Pharmacology|August 8, 2013
Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumorsYan Xin, Denise Jin, Stephen Eppler, et al.Molecular Cancer Therapeutics|November 22, 2013
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumabElaine Mai, Zhong Zheng, Youjun Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cellsNathalie Carayol, Eliza Vakana, Antonella Sassano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2015
Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian CancersKedan Lin, Bonnee Rubinfeld, Crystal Zhang, et al.Cell Death & Disease|August 13, 2021
Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolismXianjing Hu, Sarwat Fatima, Minting Chen, et al.Pageof 26